Profitability Ratios
| Ratio |
Value |
| GP Margin |
26.8% |
| EBIT Margin |
9.5% |
| EBITDA Margin |
14.4% |
| Operating Margin |
10.9% |
| Pretax Margin |
7.9% |
| Cont. Ops Margin |
6.3% |
| Net Margin |
6.3% |
| Bottom Line Margin |
6.3% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.42 |
| Quick Ratio |
1.23 |
| Solvency Ratio |
0.160 |
| Cash Ratio |
0.19 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
1.28 |
| Forward PEG |
1.28 |
| Price/Book |
2.42 |
| Price/Sales |
1.50 |
| Price/FCF |
17.31 |
| Price/Op Cash Flow |
12.72 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3917 |
| Debt/Equity |
0.8358 |
| Debt/Capital |
0.4553 |
| Long-Term Debt/Capital |
0.4009 |
| Financial Leverage |
2.13 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
10.44 |
| Operating Cash Flow Ratio |
0.581 |
| Operating Cash Flow/Sales |
11.8% |
| Free Cash Flow/Operating Cash Flow |
73.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.94 |
| Interest Coverage |
6.7657 |
| Short-Term Operating Cash Flow Coverage |
2.36 |
| Operating Cash Flow Coverage |
0.23 |
| Capital Expenditure Coverage |
3.78 |
| Dividend + Capital Expenditure Coverage |
2.43 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
27.4615% |
| Dividend Yield |
1.1532% |
| Dividend Yield % |
1.1532% |
| Dividend Per Share |
2.8930 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
167.69 |
| EPS |
10.535 |
| Debt/Share |
89.2800 |
| Cash/Share |
6.40 |
| Book Value/Share |
103.81 |
| Tangible BV/Share |
-21.02 |
| Equity/Share |
103.60 |
| Operating Cash Flow/Share |
19.718 |
| Capital Expenditure/Share |
5.222 |
| FCF/Share |
14.495 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.791 |
| Earnings Before Tax/EBIT |
0.730 |
| Price/Fair Value |
2.42 |
| Debt/Market Cap |
0.3096 |
| Effective Tax Rate |
20.7% |
| Enterprise Value Multiple |
13.69 |
LH - Labcorp Holdings Inc.